Skip to main content
Figure 9 | BMC Cancer

Figure 9

From: Down-regulation of NF kappa B activation is an effective therapeutic modality in acquired platinum-resistant bladder cancer

Figure 9

Effect of DHMEQ on tumor growth in T24PR mouse xenograft model. T24PR cells (2 × 106 cells) were implanted in the flank of athymic nude mice. Seven days after implantation, daily intraperitoneal administration of 2 mg/kg of DHMEQ was started. The tumor volume of each animal was monitored and compared with that in the vehicle-treated control group. : *< 0.05, compared with control group. Each value represents the mean ± SE.

Back to article page